- Home
- DIBS vs FBRX Comparison
DIBS vs FBRX Comparison
Compare DIBS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- FBRX
- Stock Information
- Founded
- DIBS 2000
- FBRX N/A
- Country
- DIBS United States
- FBRX United States
- Employees
- DIBS N/A
- FBRX N/A
- Industry
- DIBS Catalog/Specialty Distribution
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- FBRX Health Care
- Exchange
- DIBS Nasdaq
- FBRX Nasdaq
- Market Cap
- DIBS 149.7M
- FBRX 170.0M
- IPO Year
- DIBS 2021
- FBRX N/A
- Fundamental
- Price
- DIBS $5.32
- FBRX $19.40
- Analyst Decision
- DIBS Hold
- FBRX Strong Buy
- Analyst Count
- DIBS 1
- FBRX 4
- Target Price
- DIBS N/A
- FBRX $67.00
- AVG Volume (30 Days)
- DIBS 465.0K
- FBRX 109.5K
- Earning Date
- DIBS 11-07-2025
- FBRX 11-14-2025
- Dividend Yield
- DIBS N/A
- FBRX N/A
- EPS Growth
- DIBS N/A
- FBRX N/A
- EPS
- DIBS N/A
- FBRX N/A
- Revenue
- DIBS $89,422,000.00
- FBRX N/A
- Revenue This Year
- DIBS $2.87
- FBRX N/A
- Revenue Next Year
- DIBS $3.26
- FBRX N/A
- P/E Ratio
- DIBS N/A
- FBRX N/A
- Revenue Growth
- DIBS 3.49
- FBRX N/A
- 52 Week Low
- DIBS $2.30
- FBRX $4.90
- 52 Week High
- DIBS $5.51
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- DIBS 72.18
- FBRX 67.89
- Support Level
- DIBS $4.59
- FBRX $18.11
- Resistance Level
- DIBS $5.42
- FBRX $21.99
- Average True Range (ATR)
- DIBS 0.41
- FBRX 1.79
- MACD
- DIBS 0.04
- FBRX 0.65
- Stochastic Oscillator
- DIBS 90.00
- FBRX 77.55
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).